StockData
Cosmos Health Inc. logo

Cosmos Health Inc. (COSM) stock

COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30107% above fair value
$2.85+0.36 (+14.46%)

Close on Nov 17, 2026Market cap $286.81MP/E –Yield –

Cosmos Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cosmos Health's price to sales ratio was 0.2× on Nov 10, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 0.7×, with a median of 0.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20260.2×−0.0
2025Dec 31, 20250.3×−0.0
2024Dec 31, 20240.3×−0.1
2023Dec 29, 20230.4×+0.3
2022Dec 30, 20220.1×+0.0
2021Dec 31, 20210.0×−0.0
2020Dec 31, 20200.1×+0.0
2019Dec 31, 20190.0×−0.0
2018Dec 31, 20180.1×−0.2
2017Dec 29, 20170.2×–

More Cosmos Health figures

See a number that looks wrong?